Reckitt Benckiser Group (LON:RB) PT Set at GBX 5,800 by Credit Suisse Group

Credit Suisse Group set a GBX 5,800 ($75.79) target price on Reckitt Benckiser Group (LON:RB) in a report released on Monday morning, Borsen Zeitung reports. The brokerage currently has a sell rating on the stock.

Other equities analysts have also recently issued reports about the company. Goldman Sachs Group set a GBX 6,870 ($89.77) price objective on Reckitt Benckiser Group and gave the company a neutral rating in a report on Tuesday, June 25th. Jefferies Financial Group raised AGCO from a hold rating to a buy rating and lifted their price objective for the company from $70.00 to $90.00 in a report on Monday, June 24th. Barclays reaffirmed an overweight rating and issued a GBX 3,150 ($41.16) price objective on shares of in a report on Wednesday, June 5th. Morgan Stanley reaffirmed an overweight rating on shares of in a report on Thursday, June 20th. Finally, UBS Group cut Telstra from a buy rating to a neutral rating in a report on Monday, July 1st. Three equities research analysts have rated the stock with a sell rating, four have given a hold rating and twelve have given a buy rating to the stock. The company currently has a consensus rating of Hold and an average price target of GBX 7,211.11 ($94.23).

Shares of LON RB opened at GBX 6,590 ($86.11) on Monday. The firm has a market cap of $46.73 billion and a PE ratio of 21.62. The company has a debt-to-equity ratio of 80.49, a current ratio of 0.65 and a quick ratio of 0.47. The firm has a fifty day moving average of GBX 6,380.64. Reckitt Benckiser Group has a fifty-two week low of GBX 5,559 ($72.64) and a fifty-two week high of GBX 7,174 ($93.74).

In other news, insider Andrew R. J. Bonfield bought 146 shares of the stock in a transaction on Tuesday, May 21st. The stock was acquired at an average price of GBX 6,290 ($82.19) per share, with a total value of £9,183.40 ($11,999.74). Also, insider Christopher Sinclair bought 1,076 shares of the stock in a transaction on Thursday, May 23rd. The stock was purchased at an average cost of GBX 6,375 ($83.30) per share, with a total value of £68,595 ($89,631.52).

Reckitt Benckiser Group Company Profile

Reckitt Benckiser Group plc manufactures, markets, and sells health, hygiene, and home products. The company offers acne treatment creams, facial washes, and cleansing pads; disinfection, hygiene, and first aid products; condoms, sex toys, and lubricants; heartburn and indigestion solutions; and cough and chest congestion, multi-symptom, and sinus remedies for adults and children under the Clearasil, Dettol, Durex, Gaviscon, and Mucinex brands.

Read More: What is systematic risk?

Analyst Recommendations for Reckitt Benckiser Group (LON:RB)

Receive News & Ratings for Reckitt Benckiser Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Reckitt Benckiser Group and related companies with's FREE daily email newsletter.